Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Plos One
|
June 23, 2012
Human SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson's disease
Elisa Belluzzi, Marco Bisaglia, Elisabetta Lazzarini, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|
September 9, 2015
TGF-beta1 pathway activation and adherens junction molecular pattern in nonsyndromic mitral valve prolapse
Stefania Rizzo, Cristina Basso, Elisabetta Lazzarini, et al.
Circulation
|
November 19, 2014
Nonischemic left ventricular scar: sporadic or familial? Screen the genes, scan the mutation carriers
Kalliopi Pilichou, Massimiliano Mancini, Ilaria Rigato, et al.
Orphanet Journal of Rare Diseases
|
April 4, 2016
Arrhythmogenic cardiomyopathy
Kalliopi Pilichou, Gaetano Thiene, Barbara Bauce, et al.
Journal of Cellular and Molecular Medicine
|
October 14, 2025
Unique Genetic and Epigenetic Alterations in Glioblastoma Long-Term Survivors: Insights From Two Clinical Cases
Elena Anghileri, Evelina Miele, Sara Patrizi, et al.
Human Mutation
|
February 14, 2015
The ARVD/C genetic variants database: 2014 update
Elisabetta Lazzarini, Jan D H Jongbloed, Kalliopi Pilichou, et al.
Journal of Personalized Medicine
|
August 29, 2024
Is There a Link between Chronic Obstructive Pulmonary Disease and Lung Adenocarcinoma? A Clinico-Pathological and Molecular Study
Francesca Lunardi, Giorgia Nardo, Elisabetta Lazzarini, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 19, 2025
Baseline levels and dynamic changes of cfDNA, tumor fraction and mutations to anticipate the clinical course of small cell lung cancer (SCLC) patients treated with first-line atezolizumab and chemotherapy: an hypothesis generating study (CATS/ML43257)
Giulia Pasello, Giulia Pigato, Daniela Scattolin, et al.
Cancers
|
April 14, 2025
Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept Study
Elisa Pinto, Elisabetta Lazzarini, Filippo Pelizzaro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 23, 2025
PIK3CA mutations and first-line outcomes in endocrine-resistant HR+/HER2- metastatic breast cancer: A multicentric real-world study
Maria Vittoria Dieci, Grazia Vernaci, Chiara Colangelo, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Plos One
|
June 23, 2012
Human SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson's disease
Elisa Belluzzi, Marco Bisaglia, Elisabetta Lazzarini, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|
September 9, 2015
TGF-beta1 pathway activation and adherens junction molecular pattern in nonsyndromic mitral valve prolapse
Stefania Rizzo, Cristina Basso, Elisabetta Lazzarini, et al.
Circulation
|
November 19, 2014
Nonischemic left ventricular scar: sporadic or familial? Screen the genes, scan the mutation carriers
Kalliopi Pilichou, Massimiliano Mancini, Ilaria Rigato, et al.
Orphanet Journal of Rare Diseases
|
April 4, 2016
Arrhythmogenic cardiomyopathy
Kalliopi Pilichou, Gaetano Thiene, Barbara Bauce, et al.
Journal of Cellular and Molecular Medicine
|
October 14, 2025
Unique Genetic and Epigenetic Alterations in Glioblastoma Long-Term Survivors: Insights From Two Clinical Cases
Elena Anghileri, Evelina Miele, Sara Patrizi, et al.
Human Mutation
|
February 14, 2015
The ARVD/C genetic variants database: 2014 update
Elisabetta Lazzarini, Jan D H Jongbloed, Kalliopi Pilichou, et al.
Journal of Personalized Medicine
|
August 29, 2024
Is There a Link between Chronic Obstructive Pulmonary Disease and Lung Adenocarcinoma? A Clinico-Pathological and Molecular Study
Francesca Lunardi, Giorgia Nardo, Elisabetta Lazzarini, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 19, 2025
Baseline levels and dynamic changes of cfDNA, tumor fraction and mutations to anticipate the clinical course of small cell lung cancer (SCLC) patients treated with first-line atezolizumab and chemotherapy: an hypothesis generating study (CATS/ML43257)
Giulia Pasello, Giulia Pigato, Daniela Scattolin, et al.
Cancers
|
April 14, 2025
Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept Study
Elisa Pinto, Elisabetta Lazzarini, Filippo Pelizzaro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 23, 2025
PIK3CA mutations and first-line outcomes in endocrine-resistant HR+/HER2- metastatic breast cancer: A multicentric real-world study
Maria Vittoria Dieci, Grazia Vernaci, Chiara Colangelo, et al.
Page
of 2